CDSCO medical device labelling guidelines in India is governed by the Medical Devices Rules, 2017. These labelling guidelines help healthcare providers and patients identify and use devices correctly, reducing risks of misuse or counterfeit products. They also strengthen traceability for recalls, align India’s practices with international norms, and promote accountability and ethical standards. Therefore, CDSCO medical device labelling requirements protect consumers while enabling manufacturers to demonstrate compliance and secure market access.
Regulatory framework for CDSCO medical device labelling requirements
Regulatory framework for CDSCO medical device labelling requirements is anchored in the Medical Devices Rules, 2017 and supplemented by the Legal Metrology (Packaged Commodities) Rules, 2011. Together, these establish the standards for what information must appear on device labels to ensure safety, transparency, and accountability. CDSCO enforces these requirements to guarantee that devices carry essential details, such as manufacturer/importer information, batch/lot numbers, sterilization status, single-use declarations, warnings, intended use, and pricing. This framework not only protects patients and healthcare providers but also harmonizes India’s practices with international norms. Thus, it enables smoother regulatory audits, better traceability, and stronger market confidence.
- Medical Devices Rules, 2017: Issued under the Drugs & Cosmetics Act, 1940. It governs classification, registration, QMS, and medical device labelling.
- Legal Metrology Act, 2009 & Packaged Commodities Rules, 2011: It ensures standardization in weights, measures, and consumer declarations.
CDSCO medical device labelling requirements: Core components
We have discussed in details the core components of CDSCO medical device labelling requirements.
1. Device identification
The medical device label must state the trade name, common name, and description of the device. This ensures clarity for healthcare providers and patients, reducing confusion with similar products. Proper identification supports traceability in case of recalls or adverse events. It also helps regulators verify that the device is marketed for its approved purpose.
2. Manufacturer and importer details
CDSCO medical device labelling requirements necessitate the name and address of the manufacturer be displayed. For imports, the authorized representative in India has to be mentioned on the label. This provides accountability and a clear point of contact for regulators and consumers. Moreover, it ensures transparency in case of complaints, recalls, or inspections. Such details build trust and align India with global regulatory practices.
3. Batch/lot number and dates
Each device must carry a batch or lot number, along with manufacturing and expiry dates. These identifiers are essential for quality control and supply chain traceability. They allow quick identification of defective or expired products during audits or recalls. This requirement safeguards patient safety by preventing use of compromised devices.
4. Intended use and instructions
Labels must specify the intended purpose of the medical device and provide clear usage directions. This ensures correct application and use by healthcare providers and patients. Misuse due to unclear instructions can lead to ineffective treatment or harm. Furthermore, including intended use also helps regulators confirm that the device is marketed for approved applications only.
5. Warnings and precautions
Labels must include safety warnings, contraindications, and precautionary statements. These alerts protect patients and practitioners from risks associated with improper use. They highlight limitations of the device, thereby ensuring it is not used in unsuitable conditions. Moreover, CDSCO mandates warnings to align with international patient safety standards.
6. Sterilization status
The label must indicate whether the device is sterile or non-sterile. If sterile, the method of sterilization (e.g., EO gas, gamma radiation) should be specified. This helps healthcare providers handle the device appropriately and avoid contamination risks. Furthermore, clear mention of sterilization status ensures compliance with infection control protocols.
7. Single-use declaration
Devices intended for single use must carry a clear “Single Use Only” or “Do Not Reuse” statement. This prevents unsafe reuse that could lead to cross-contamination or malfunction. Prominent marking reduces liability for manufacturers and protects patients. CDSCO requires this to align with WHO and ISO safety practices.
8. Storage and handling instructions
Labels must specify storage conditions, such as temperature, humidity, or handling requirements. This ensures the device maintains integrity and effectiveness until use. Improper storage can compromise performance and patient safety. Clear instructions help distributors, hospitals, and pharmacies maintain compliance with quality standards.
9. Sample/reference number
As per CDSCO medical device labelling requirements, a unique sample, reference, or catalogue number must be included for identification. This aids inventory management and ensures traceability across hospitals, distributors, and regulators. It simplifies reporting during adverse events or recalls. Such identifiers strengthen supply chain transparency and regulatory oversight.
10. Quantity and pricing (Legal Metrology Compliance)
For packaged devices, the label must declare net quantity, maximum retail price (MRP), and consumer information. This ensures transparency and protects consumers from unfair trade practices. It also aligns medical devices with broader consumer protection laws in India. Notably, compliance with Legal Metrology rules is mandatory alongside CDSCO regulations.
Best practices to comply with CDSCO medical device labelling requirements
- Clarity and readability: Labels must use simple, unambiguous language that can be easily understood by healthcare providers and patients. Font size, color contrast, and placement should ensure legibility even in clinical environments. Additionally, overcrowding with excessive details should be avoided to prevent confusion. Critical information, such as expiry date, warnings, and sterilization status, should be highlighted prominently.
- Regulatory alignment: Labelling must comply with the Medical Devices Rules, 2017 and the Legal Metrology (Packaged Commodities) Rules, 2011. All mandatory elements, such as manufacturer/importer details, batch/lot number, expiry/manufacture dates, intended use, warnings, sterilization status, single-use declaration, storage conditions, and pricing, must be included. Moreover, imported devices must also display the authorized representative’s details in India. Furthermore, regular updates to labelling templates should be made to reflect CDSCO circulars and guidance notes.
- Safety emphasis: Labels must prominently display warnings, contraindications, and precautionary statements to prevent misuse. Devices intended for single use should carry clear “Single Use Only” or “Do Not Reuse” markings. Additionally, sterilization status and method (e.g., EO gas, gamma radiation) must be specified to guide safe handling. Moreover, as per CDSCO medical device labelling requirements, storage and handling instructions should be included to maintain device integrity and patient safety.
- Traceability and accountability: Batch/lot numbers and reference/catalogue numbers must be included for supply chain tracking. These identifiers allow quick identification during recalls or adverse event reporting. Consistency across packaging, instructions for use (IFUs), and promotional materials is essential. Traceability practices should align with ISO 13485 and international regulatory standards.
- Consumer transparency: For packaged devices, net quantity, maximum retail price (MRP), and consumer information must be declared. This ensures transparency and protects consumers from unfair trade practices. Moreover, labelling must align with the approved intended use and CDSCO registration. Additionally, contact details for consumer queries or complaints should also be provided.
- Durability and quality: Labels must be printed on materials that withstand handling, sterilization, and storage conditions. They should remain intact and legible throughout the product lifecycle. Environmental stress testing (temperature, humidity, transport) should be conducted to validate durability. Furthermore, Good Manufacturing Practices (GMP) must be applied to labelling processes to ensure consistency and reliability.
In this blog, we have compiled the CDSCO medical device labelling requirements in India. Are you planning to launch a medical device in India? Confused about the CDSCO guidelines for labelling medical devices? Well, you have landed in the right place. We at Pharmadocx Consultants provide guidance and support with labelling medical devices for the Indian market. For any assistance with CDSCO medical device licensing or regulatory support, drop an email at [email protected] or call/Whatsapp on 9996859227.
